weight loss

Novo Nordisk’s $9B Shock Bid Snatches US Weight-Loss Biotech from Pfizer – Stocks React Big

Bidding War Ignites for Obesity Biotech Novo’s takeover push marks a sudden escalation in the weight-loss drug wars. The Danish company – maker of Wegovy and Ozempic – broke ranks on Oct.

31 October 2025

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Stock Price & Recent Performance Pfizer’s stock has been rangebound in the low-to-mid $20s for much of 2025. By late September, PFE traded around $23.60 – about 9% below its price a

30 October 2025

Drug Pricing · Investment News · NYSE:PFE · Pharmaceuticals · Stock Market · Trump Administration

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Boardroom Shake-Up Spurs Investor Nerves Novo’s stock slide accelerated this week amid a dramatic boardroom conflict. On Oct. 21, the Novo Nordisk Foundation (the company’s controlling shareholder) announced it would remove chair

22 October 2025

Business Rivalry · Corporate News · NYSE:NVO · Pharmaceuticals · Stock Market · Weight Loss

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Menopause Launch Sparks Surge in HIMS Stock Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is

17 October 2025

Health · Market Trends · Menopause · NYSE:HIMS · Pharmaceuticals · Weight Loss

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s Weight-Loss Crown at Risk? NVO Stock Slumps Amid Surprise Deals – What’s Next

NVO Stock Slides as Weight-Loss Hype Cools Novo Nordisk’s stock has been on a wild ride. After becoming Europe’s most valuable company in 2022–2023 on the back of its smash-hit obesity drug

17 October 2025

Healthcare · Industry News · NASDAQ:AKRO · NASDAQ:OMER · NYSE:LLY · NYSE:NVO · Pharmaceuticals · Stock Market · Weight Loss

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer (PFE) Stock Soars on Trump’s Drug-Price Pact and $7.3B Weight-Loss Deal

Stock Performance (Sep 2025) On Sept 30, 2025 Pfizer closed around $24.40 reuters.com. Over the past year PFE underperformed the pharma sector (latest 52-week range ~$20.91–30.43 reuters.com). Its trailing P/E is 12.64×

30 September 2025

Business News · NYSE:PFE · Pharmaceuticals · Stock Market · Stocks · Trump Administration · Weight Loss

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

“It’s never been more clear that we are delivering exactly what millions of people have been waiting for,” said HIMS CEO Andrew Dudum after Q2 results investors.hims.com. With analysts ranging from “Sell”

29 September 2025

FDA Regulation · Healthcare Stocks · Investment News · Market Trends · NYSE:HIMS · Stock Market · Weight Loss

Hidden Galaxies, “4-in-1” Weight-Loss Drug, and Lightning’s Dirty Secret: Top Science News (Aug 30–31, 2025)

Key Facts Space & Astronomy: Cosmic Revelations Webb Discovers “Impossible” Early Galaxies: Astronomers using NASA’s James Webb Space Telescope (JWST) are astonished by 300 unusually bright objects that may be among the

31 August 2025

Astronomy · Medicine · Physics · Science News · Weekend Recap